Ozempic maker to cut thousands of jobs
Novo Nordisk plans to cut 9,000 jobs globally, including 5,000 in Denmark, as the Ozempic and Wegovy maker faces increased competition from Eli Lilly in the obesity market.
← Back to stories
National7 articles from 7 sources across the spectrum· Updated 385d ago
5 across the spectrum · tap a section to jump
How each side is putting it
Left
0 viewpointsNo Left coverage yet.
A blind spot on this side of the story.
Center
3 viewpointsWegovy and Ozempic maker to cut 9,000 jobs amid stiff competition from Eli Lilly
Right
2 viewpointsOther outlets
International, entertainment and tech outlets, by their rating. Not counted in the bar above. How we count coverage
Left
2 articlesWegovy maker Novo Nordisk to cut 9,000 jobs amid increased competition
Center
0 articlesNone
Right
0 articlesNone